ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CNMD CONMED Corporation

74.04
0.88 (1.20%)
29 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
CONMED Corporation NYSE:CNMD NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.88 1.20% 74.04 74.48 73.26 73.395 175,252 22:00:00

Form 8-K - Current report

20/09/2024 10:07pm

Edgar (US Regulatory)


CONMED Corp false 0000816956 0000816956 2024-09-16 2024-09-16

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15 (d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 16, 2024

 

 

CONMED CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39218   16-0977505

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

11311 Concept Blvd  
Largo, FL   33773
(Address of principal executive offices)   (Zip code)

(727) 392-6464

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (See General Instruction A.2 below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Rule 12(b) of the Act

 

Title of each class

 

Trading

Symbol

 

Name of each exchange

on which registered

Common Stock, $0.01 par value   CNMD   NYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 16, 2024, Eric B. Staves, Vice President, Corporate Controller, informed CONMED Corporation (the “Company”) that, effective September 27, 2024, he plans to leave the Company to pursue an executive opportunity. Kimberly A. Lockwood, Director of Financial Reporting & Controls, will serve as Interim Corporate Controller, effective September 30, 2024. Todd W. Garner, Executive Vice President of Finance and Chief Financial Officer, will assume the role of Principal Accounting Officer. Terence M. Berge, retired Vice President, Corporate Controller, continues to serve as Special Advisor to the Company and remains available to support the Company and Ms. Lockwood.

Ms. Lockwood joined the Company in 2005 as the Director, Financial Reporting & Controls. Prior to joining the Company, Ms. Lockwood was employed by PricewaterhouseCoopers LLP’s Assurance and Business Advisory Services group. Ms. Lockwood is a certified public accountant and holds a Bachelor of Science degree in Accounting from Le Moyne College.


Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: September 20, 2024     CONMED CORPORATION
    (Registrant)
    By:  

/s/ Todd W. Garner

    Name:   Todd W. Garner
    Title:   Executive Vice President-Chief Financial Officer
v3.24.3
Document and Entity Information
Sep. 16, 2024
Cover [Abstract]  
Entity Registrant Name CONMED Corp
Amendment Flag false
Entity Central Index Key 0000816956
Document Type 8-K
Document Period End Date Sep. 16, 2024
Entity Incorporation State Country Code DE
Entity File Number 001-39218
Entity Tax Identification Number 16-0977505
Entity Address, Address Line One 11311 Concept Blvd
Entity Address, City or Town Largo
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33773
City Area Code (727)
Local Phone Number 392-6464
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.01 par value
Trading Symbol CNMD
Security Exchange Name NYSE
Entity Emerging Growth Company false

1 Year CONMED Chart

1 Year CONMED Chart

1 Month CONMED Chart

1 Month CONMED Chart

Your Recent History

Delayed Upgrade Clock